Radiosensitivity of neuroendocrine cancer cells to 177Lu-DOTATATE and radiobiological implications for peptide radionuclide therapy

被引：0
|
作者：
Tamborino, G. [1 ,2 ]
Engbers, P. [1 ,2 ]
de Wolf, T. [1 ,2 ]
Reuvers, T. [1 ,2 ]
Konijnenberg, M. [1 ]
Nonnekens, J. [1 ,2 ]
机构：
[1] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands
[2] Erasmus MC, Dept Mol Genet, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-146
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [41] Disturbing the redox balance as a new radiosensitizing strategy for Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
    Delbart, W.
    Marin, G.
    Stamatopoulos, B.
    Ghanem, G. E.
    Flamen, P.
    Wimana, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S59 - S59
  • [42] Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE
    Zandee, Wouter T.
    Feelders, Richard A.
    Duijzentkunstz, Daan A. Smit
    Hofland, Johannes
    Metselaar, R. Mick
    Oldenburg, Rogier A.
    van Linge, Anne
    Kam, Boen L. R.
    Teunissen, Jaap J. M.
    Korpershoek, Esther
    Hendriks, Johanna M.
    Abusaris, Huda
    Slagter, Cleo
    Franssen, Gaston J. H.
    Brabander, Tessa
    De Herder, Wouter W.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (01) : 45 - 53
  • [43] Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Individuals with Neck or Mediastinal Paraganglioma (PGL)
    Zovato, S.
    Kumanova, A.
    Dematte, S.
    Sansovini, M.
    Bodei, L.
    Di Sarra, D.
    Casagranda, E.
    Severi, S.
    Ambrosetti, A.
    Schiavi, F.
    Opocher, G.
    Paganelli, G.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (05) : 411 - 414
  • [44] Patient-Specific Dosimetry of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy with High Activities
    Beykan, S.
    Eberlein, U.
    Werner, R. A.
    Lapa, C.
    Buck, A. K.
    Kudlich, T.
    Lassmann, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S33 - S33
  • [45] Gallbladder Visualization in Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE A Potential Mimicker of Hepatic Metastases
    Diekmann, Johanna
    Werner, Rudolf A.
    Ross, Tobias L.
    Derlin, Thorsten
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (12) : E521 - E522
  • [46] Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the phase I-II Milan protocol
    Bodei, L.
    Cremonesi, M.
    Grana, C. M.
    Baio, S. M.
    Bartolomei, M.
    Ferrari, M.
    Iodice, S.
    Lombardo, D.
    Martano, L.
    Chinol, M.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S266 - S267
  • [47] A Prospective study of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE and Concurrent Capecitabine in Metastatic Paragangliomas
    Ballal, S.
    Yadav, M. P.
    Yadav, D.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S184 - S184
  • [48] Peptide Receptor Radionuclide Therapy (PRRT) Using 177Lu-DOTATATE: Early Clinical and Dosimetric Results
    Garkavij, M.
    Nickel, M.
    Sjogreen-Gleisner, K.
    Ljungberg, M.
    Strand, S. E.
    Ohlsson, T.
    Tennvall, J.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 113 - 113
  • [49] Peptide receptor radionuclide therapy (PRRT) using 177Lu-Dotatate:: Early clinical and dosimetric results
    Garkavij, M.
    Sjogreen-Gleisner, K.
    Nickel, M.
    Ohlsson, T.
    Wingardh, K.
    Tennvall, J.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) : 524 - 525
  • [50] Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting
    Kalshetty, Ashwini
    Ramaswamy, Anant
    Ostwal, Vikas
    Basu, Sandip
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1143 - 1149
12345